NEW YORK, Nov 27 – Aclara BioSciences said that a trial judge has granted the company’s request to reduce a $52 million jury award in a microfluidics trade secret lawsuit with Caliper Technologies by $17 million .

“In addition, we intend to appeal the remaining $35 million and believe that we have strong grounds on which to base that appeal," Joseph Limber, president and CEO of Aclara said in a statement released Sunday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.